shouldiuse.io

VERDICT

Should I use Great Question?

Great Question is the all-in-one UX research platform used by 300+ teams to recruit participants, run studies, and turn insights into product decisions. Start free. - greatquestion.co

Depends. Buy if your team runs research continuously and wants recruiting, studies, and a repository in one tool. Skip it if you do a few interviews a quarter — a scheduling tool plus a spreadsheet is enough.

Confidence

Medium. Based on ~20 relevant public sources; many indexed results were noise. Pricing and user-review evidence was thin.

Ratings

  • Value for moneyNo public pricing figures in evidence
  • Ease of use
  • Feature depth
  • Support qualityNo substantive support evidence found
  • Security posture

Pricing

Free

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
Free tierYes
ProfessionalUndisclosed

Best for

  • Product teams running weekly research
  • Mid-size SaaS research ops
  • Teams needing HIPAA-compliant studies
  • Solo researchers recruiting participants

Not for

  • Small teams doing occasional interviews
  • Buyers wanting only analysis — Dovetail fits better
  • Enterprises needing massive participant panels
  • Anyone requiring transparent public pricing

Gotchas - check before you buy

medium

Professional tier price undisclosed; expect a sales call

medium

Sources conflict on plans (G2: one edition; PricingSaaS: two) — confirm packaging before signing

low

22-review G2 base makes support quality and reliability hard to vet

Pros and cons

Pros

  • All-in-one: recruiting, studies, synthesis, repository
  • G2 reviewers consistently praise ease of use
  • Strong participant recruiting and panel management
  • HIPAA-compliant option for healthcare research
  • AI moderation focus, per Maze comparison

Cons

  • Only 22 G2 reviews — thin proof base
  • No public pricing; tier count unclear across sources
  • Early-stage: $2.5M seed (2021), Series A only Nov 2025
  • Crowded field: Maze, Dovetail, Rally compete head-on

Sources & method

Analyzed 9/20/2026 - 15 sources - No known vulnerabilities found in the sources reviewed.

official x2review x8security x3news x2

Key stats

  • Ease of use: 4/5

    Rating

  • Free

    Starting price

  • 15

    Sources

  • Analyzed

  • Value for money. No public pricing figures in evidence
  • Ease of use: 4/5. G2 reviewers consistently praise ease of use
  • Feature depth: 4/5. All-in-one: recruit, run studies, repository, AI moderation
  • Support quality. No substantive support evidence found
  • Security posture: 4/5. HIPAA option, trust center, HackerOne bug bounty
  • 22 G2 reviews thin sample for a 2026 listing
  • 300+ Teams using it per vendor
  • $13M Series A Funding Inovia, Nov 2025
  • Yes Free tier "Start free" per vendor

Pricing

Free

Free

  • Start free per vendor tagline
  • Limits not published

Professional

Undisclosed

  • Named on Vendr marketplace
  • Contact sales for quote

Security

No known vulnerabilities found in the sources reviewed.

What users say

G2 reviewers consistently praise ease of use, though 22 reviews exist.

Companies that use it

  • Canva
  • Miro
  • Brex
Full analysis

Based on ~20 relevant public sources; many indexed results were noise. Pricing and user-review evidence was thin.

All-in-one UX research platform (recruit + studies + repo). Buy for steady research; overkill for occasional interviews.

Methodology

Based on ~20 relevant public sources; many indexed results were noise. Pricing and user-review evidence was thin.

Sources

  1. review
  2. review
  3. review
  4. review
  5. review
  6. review
  7. review
  8. review
  9. official
  10. official
  11. Great Question Trust Centertrust.greatquestion.co
    security
  12. security
  13. security
  14. news
  15. news

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.